$LJPC News Article - La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis https://marketwirenews.com/news-releases/la-j...11186.html
(1)
(0)
La Jolla Pharmaceutical Company. (LJPC) Stock Research Links